APOE ε4 carrier status modifies plasma p‐tau181 concentrations in cognitively healthy super‐seniors

Author:

Cooper Jennifer G.12ORCID,Ghodsi Mohammad12,Stukas Sophie12,Leach Stephen3,Brooks‐Wilson Angela34,Wellington Cheryl L.1256

Affiliation:

1. Djavad Mowafaghian Centre for Brain Health University of British Columbia Vancouver British Columbia Canada

2. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver British Columbia Canada

3. Canada's Michael Smith Genome Sciences Centre, BC Cancer Vancouver British Columbia Canada

4. Department of Biomedical Physiology and Kinesiology Faculty of Science Simon Fraser University Burnaby British Columbia Canada

5. School of Biomedical Engineering University of British Columbia Vancouver British Columbia Canada

6. International Collaboration on Repair Discoveries University of British Columbia Vancouver British Columbia Canada

Abstract

AbstractINTRODUCTIONThis study investigates the effect of apolipoprotein E (APOE) genotype on neurology plasma biomarkers in cognitively healthy Super‐Seniors.METHODSThree hundred seventy plasma specimens from Super‐Senior participants ≥ 85 years old, who have never been diagnosed with dementia, cancer, diabetes, cardiovascular, or major pulmonary disease, were analyzed on the Quanterix Simoa HD‐X analyzer using commercial Neurology 4‐plex E and phosphorylated tau (p‐tau)181 assays.RESULTSEighty (22%) participants were APOE ε4 carriers and 290 (73%) were non‐carriers. No significant differences were found between APOE ε4 carriers and non‐carriers regarding age, sex, or Mini‐Mental State Examination scores. In APOE ε4 carriers, plasma amyloid beta 42/40 was lower and p‐tau181 and glial fibrillary acidic protein were higher compared to non‐APOE ε4 carriers. After adjusting for demographic variables, p‐tau181 was the only biomarker to remain significantly associated with APOE ε4 carrier status.DISCUSSIONAPOE ε4 genotype modifies plasma p‐tau181 concentration in seniors resilient to age‐related clinical disease, suggesting that some Super‐Seniors may have Alzheimer's disease pathology without progressing to cognitive decline.Highlights Healthy seniors enable identification of associations that may be masked by disease. Plasma phosphorylated tau (p‐tau)181 concentrations associate with apolipoprotein E (APOE) ε4 carriership in healthy seniors. APOE should be accounted for when interpreting p‐tau181, regardless of disease.

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3